C4XD — C4X Discovery Holdings Share News
0.000.00%
- £20.75m
- £7.88m
- £1.71m
- 62
- 95
- 21
- 64
REG - C4X Discovery - Exercise of Options, Issue of Equity and TVR
AnnouncementREG - C4X Discovery - Divestment of Orexin-1 to Indivior for £15.95m
AnnouncementREG - C4X Discovery - C4X Discovery Holdings plc: Board Change
AnnouncementREG - C4X Discovery - MALT-1 Inhibitor Programme Update
AnnouncementREG - C4X Discovery - Half Year Results
AnnouncementREG - C4X Discovery - Notice of Results
AnnouncementREG - C4X Discovery - Block Listing Interim Review
AnnouncementREG - C4X Discovery - C4XD and Garvan Institute collaboration
AnnouncementREG - C4X Discovery - Result of AGM
AnnouncementREG - C4X Discovery - MALT-1 Inhibitor Programme Update
AnnouncementREG - C4X Discovery - Nick Ray Appointed as Chief Scientific Officer
AnnouncementREG - C4X Discovery - Posting of 2022 Annual Report and Notice of AGM
AnnouncementREG - C4X Discovery - Full Year Results
AnnouncementREG - C4X Discovery - Notice of Final Results
AnnouncementREG - C4X Discovery - C4XD Agreement with AstraZeneca
AnnouncementREG - AIM - AIM Notice - 04/11/2022
AnnouncementREG - C4X Discovery - Exercise of Options, Issue of Equity and TVR
AnnouncementREG - C4X Discovery - C4XD and HitGen to collaborate in inflammation
AnnouncementREG - C4X Discovery - Holding(s) in Company
Announcement